Singular Genomics Systems
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $406 | $737 | $442 | $1,081 |
Gross Profit | -301 | -178 | -2,141 | -457 |
EBITDA | -14,818 | -19,188 | -23,018 | -21,308 |
EBIT | -16,509 | -20,968 | -24,740 | -22,962 |
Net Income | -16,795 | -21,254 | -25,024 | -23,249 |
Net Change In Cash | 406 | 737 | 442 | 1,081 |
Free Cash Flow | -19,795 | -18,039 | -23,728 | -19,294 |
Cash | 52,620 | 30,115 | 24,109 | 16,233 |
Basic Shares | 2,501 | 2,480 | 2,464 | 2,451 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $2,911 | $765 | $0 | $0 |
Gross Profit | -558 | -24 | -1,133 | -639 |
EBITDA | -86,496 | -84,084 | -60,546 | -26,390 |
EBIT | -93,719 | -90,116 | -61,679 | -27,029 |
Net Income | -94,820 | -88,271 | -98,889 | -28,663 |
Net Change In Cash | 2,911 | 765 | 0 | 0 |
Cost of Revenue | -125,759 | 189,566 | ||
Free Cash Flow | -74,617 | -93,116 | -56,565 | -26,253 |
Cash | 16,233 | 74,266 | 201,049 | 11,688 |
Basic Shares | 2,426 | 2,371 | 2,414 | 2,310 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$6.72 |
2024-06-30 | -$8.57 |
2024-03-31 | -$0.34 |
2023-12-31 | -$0.32 |
